pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Valbenazine
drug
save

valbenazine

Marketedupdated 5mo ago
by Lupin Ltd
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • tagApproval8 co-mentions · 4 sources
  • drugINGREZZA SPRINKLE6 co-mentions · 4 sources
  • tagSmall Molecule4 co-mentions · 4 sources
  • drugVALBENAZINE TOSYLATE4 co-mentions · 4 sources
  • companyZydus Lifesciences Ltd2 co-mentions · 2 sources

all catalysts(0)

nothing on the calendar yet

Trials studying valbenazine

  • phase4A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitorrecruitingn=50
  • phase2Valbenazine in Obsessive Compulsive Disordernot yet recruitingn=30
  • phase3Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsycompletedn=86
  • phase3Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canadaenrolling by invitationn=7
  • phase3Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophreniacompletedn=442
  • phase2Efficacy of Valbenazine for the Treatment of Trichotillomania in Adultsrecruitingn=20
  • phase4Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesiacompletedn=59
  • phase1Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazinewithdrawn

News(0)

no news has mentioned this drug yet

brand
Valbenazine
generic
valbenazine
indication
Tardive Dyskinesia
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?